Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Viewing report Order by Fax Printer Friendly PDF Brochure Send to Friend Enquire before Buying Hard Copy Antidepressants, Antipsychotics, Anxiolytics: From Chemistry and Pharmacology to Clinical Application - 2 Volume Set John Wiley and Sons Ltd, March 2007, Pages: 1,260   Description     Table of Contents        Enquire before Buying    Send to a Friend   Antidepressants and related psychiatric drugs are the most important prescription drugs worldwide, accounting for a market volume of 20 billion US$ per year. This handbook provides a complete and detailed overview of all currently available psychiatric drugs, covering more than 250 different compounds. Particular features include: - the most important information on the chemistry, pharmacology and therapeutic use of a given drug - a special layout with margin notes and compound structures allowing for quick and easy access to the desired information Written by drug developers from the pharmaceutical industry, novel drugs currently under development and new methods of treatment are listed side by side with classical drugs, allowing a direct comparison of traditional and innovative therapeutic approaches. Author information The editors all work for the Spanish-based pharmaceutical company Esteve, a world leader in neuropharmaceuticals. Helmut Buschmann is the research director of Esteve, in charge of the discovery and development of new active substances for a variety of neurological disorders. He was formerly the head of research at Gruenenthal, a Germany-based pharma company that also specialized in neuropharmaceuticals. During his time at Gruenenthal, he published a widely acclaimed book on analgesics that pioneered the integrated approach followed also in his most recent book. Product samples Antidepressants, Antipsychotics, Anxiolytics - Chapter 1 Customers who bought this item also bought Pricing and Reimbursement Issues in Psychiatry Psychiatric Drugs: New Developments and Market Analysis by Drug Class and Clinical Indication Organic and Medicinal Chemistry in Drug Discovery: Pharmas Intelligent Design Drugs of Tomorrow: Antipsychotics - Gaining Competitive Advantage From a Limited Research Base Atypical Antipsychotics: Life-Cycle Management and Future Trends Psychopharmacotherapy Market Insights: Obstacles and Opportunities in Mood Disorders and Cognitive Impairment, 2005-2012 Antidepressants - Global Strategic Business Report European Antidepressants Markets

		Top of page

All rights reserved. � Copyright 2008 Research and Markets    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster